Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

Oticon Medical Ponto Implant System MIPS study

Also known as: Ponto Implant System MIPS study, Minimally Invasive Ponto Surgery, MIPS, Ponto, Abbreviated Profile Hearing Aid Benefit (APHAB), Glasgow Benefit Inventory (GBI), BC100, NCT04279236

Oticon Medical

Primary source

Company

Oticon Medical

Program Type

Device

Modality

Cochlear/Auditory Implant

Stage

Observational/NA

Status

Completed

Target Gene

—

Route / Mode

Bone-anchored hearing implant / percutaneous abutment

Confidence

84%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-09

Geography

Canada, Spain, United States

Population

adult, bone-anchored-hearing-system, implantable-device, hearing-loss

Trial IDs

Mechanism

Percutaneous bone-anchored hearing system using the Ponto implant and skin-penetrating abutment; the sound processor transmits vibration through skull bone to the inner ear.

Indications

Hearing Loss

Notes

ClinicalTrials.gov identifies this as an Oticon Medical-funded observational study of successful bone-anchored hearing system use after implantation of the Ponto Implant System using Minimally Invasive Ponto Surgery. APHAB and GBI are patient questionnaires used as study measures, not the product or program. No posted registry results were available in this pass.

Evidence & Sources

2 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, programType, modality, mechanism, indications, stage...

IDs: NCT04279236, BC100, Ponto Implant System, MIPS, APHAB, GBI

Open

company

Supports: allCompanies, notes

IDs: Oticon Medical, Demant, Hearing Implants

Open

Key Events

2020-02-21